Here’s what you need to know:
1. Takeda Pharmaceuticals will introduce biosensors and wearable technology into a select group of clinical studies, using Koneksa Health’s technology data platform.
2. The Koneksa Health platform will allow researchers to remotely collect patient data, such as vital signs, activity levels and sleep metrics.
3. Ongoing remote data collection will help Takeda Pharmaceuticals study disease progression, treatment effects and safety profiles of its new drugs, which focus on treating oncology, gastroenterology and central nervous system conditions.
More articles on gastroenterology and endoscopy:
Women’s cancer deaths to increase by 60% through 2030: 5 colorectal cancer findings
Aspirin reduces risk of tumors with low levels of tumor-infiltrating lymphocytes: 3 study insights
Inflammatory bowel disease 3 times more common than previous estimates: 5 takeaways
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
